February 2015

NCI Standard Funding Opportunity Announcements
Current and Recent Program Announcements  |  Current and Recent Requests for Applications
Current and Recent NCI and Trans-NIH Initiatives | Requests for Proposals  |  Standard Due Dates


Rolling All Faculty Non-federal Clinical Studies

Investigator-initiated Research Grants

Supports innovative and unique clinical trials that have the potential to immediately impact the lives of cancer patients in a positive way  Looking for outstanding clinical treatment ideas and are driven to deliver new and better treatment options by designing novel, new, and/or pilot projects distinctly removed from currently funded research projects.
Due Dates: Rolling Submission of Letters of Intent
Amount & Project Period: Dollars and Length are not specified
Eligibility: New and established investigators
Contact: Linda Nolan (x6071)
Links: Funding Process  Ι  Apply for a Cancer Research Grant
  
Open All Ranks Non-federal Sarcomas

The Liddy Schriver Sarcoma Initiative
Basic & Translational Research Grants

Funds quality basic and translational research projects targeted at finding cures for sarcomas, as well as research that attempts to develop more effective treatment regimens than those currently available.
Due Dates: Open
Amount & Project Period: $50,000/year - 1-2 years
Eligibility: All Ranks
Contact: Linda Nolan, OSR (x6071)
Link: The Liddy Schriver Sarcoma Initiative
R01 NIAID

National Institute for Allergies & Infectious Diseases
February 04 (LOI) All Faculty Federal Extended Clinical trials

Investigator Initiated Extended Clinical Trial

Invites applications for implementation of investigator-initiated, milestone-driven, long-term (6 or 7 year) & incrementally funded clinical trials (all phases), and associated mechanistic studies.
Due Dates: February 04 (LOI)
March 04 (OSR) Ι March 06 (Sponsor)
Amount & Project Period: Budgets are not limited  6-7 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: PAR-15-040
R01 FDA
February 04 All Faculty Federal Orphan products

Clinical Studies of Safety and Effectiveness of Orphan Products Research Project Grant

To support clinical development of products for use in rare diseases or conditions where no current therapy exists or where product being developed will be superior to existing therapy. Supports clinical studies on safety and/or effectiveness that will either result in, or substantially contribute to, market approval of these products.
Due Dates: February 02 (OSR) Ι February 04 (Sponsor)
Amount & Project Period: Phase 1:   $250,000/year (TOTAL) - 3 years
Phase 2 & 3: $500,000/year (TOTAL) - 4 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: RFA-FD-15-001
R01 NIH

February 05 All Ranks Federal Cancer Issues

Systems Science and Health in the Behavioral and Social Sciences

NCI is interested in research projects addressing cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and continuing care of cancer patients and families of cancer patients  Projects utilizing systems science methodologies to increase breadth, depth, and quality of behavioral research in cancer prevention and control would be of interest to NCI
Due Dates: Standard dates
Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-048
R01 NIH

NEW
February 05 All Ranks Federal Dissemination & Implementation Research

Dissemination and Implementation Research in Health

Identify, develop, evaluate and refine effective & efficient methods, systems, infrastructures, and strategies to disseminate & implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment & management, quality of life improvement services, and data monitoring & surveillance reporting tools into public health and clinical practice settings focusing on patient outcomes.
Due Dates: Standard Dates w/Letter of Intent due 30 days in advance
Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: Budget not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-13-055
R01 NIAID

National Institute of Allergy and Infectious Diseases
February 05 All Ranks Federal Immunology

High Priority Immunology Grants

Basic immunology and basic immune mechanisms involved in host defense and immune-mediated diseases are of high programmatic interest.  Research addressing innate and adaptive immunity at molecular, cellular, organism, and systems level are encouraged, particularly the use of innovative animal models and studies of the human immune system
Due Dates: Standard dates
Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: Budget not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAS-15-055
UH2/UH3 NCI

February 06 (LOI) All Ranks Federal Emerging Technologies

Cancer Detection, Diagnosis, and Treatment Technologies for Global Health

Projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost devices or assays clinically comparable to currently used technologies for imaging, in vitro detection/diagnosis, prevention or treatment of cancers in humans living in LMICs
Due Dates: February 06 (Letter of Intent)
March 04 (OSR) Ι March 06 (Sponsor)
Amount & Project Period: UH2 Development Phase:   $500,000/year (Total Costs) - 2 years UH3 Validation Phase:    $1,000,000/year (Total Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-001
K-Awards NCI

CURRENT FOA NUMBERS
February 12 See Below Federal Career Development

National Cancer Institute (NCI)
New K-Award Funding Opportunity Announcement Numbers

K awards provide support for senior postdoctoral fellows or faculty-level candidates and are designed to promote career development of specific groups of individuals based on their past training and career stage. The objective is to bring candidates to the point where they are able to conduct their research independently and are competitive for major grant support.
Due Dates: Standard Dates Apply
Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: Up to $ 100,000/year for salary of recipient and $30,000 to $50,000/year for research development costs
Up to 5 years
Contact: Linda Nolan(x6071)
FOA Links: 1.  NCI Mentored Research Scientist Development Award to Promote Diversity (K01)(PAR-15-064)
2.  Cancer Prevention, Control, Behavioral Sciences, and Population Sciences Career Development Award (K07) (PAR-15-033)
3.  NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08) (PAR-15-060)
4.  NCI Transition Career Development Award (K22) (PAR-15-056) 5.  NCI Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23) (PAR-15-062)
6.  NCI Transition Career Development Award to Promote Diversity (K22) (PAR-15-063)
K99/R00 NIH

NEW
February 12 Postdocs Federal Career Development

NIH Pathway to Independence Award (K99/R00)

Designed to facilitate a timely transition of outstanding postdoctoral researchers from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions
Due Dates: Standard dates
Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: K99: Salary Support: Up to $100,000 plus fringe benefits /year. Research Support:  $30,000/year   1 - 2 years
R00:  $249,000 (Direct Costs)/year  - 3 years
Eligibility: <4 years of postdoctoral research experience at initial or subsequent application, and be in mentored, postdoctoral training position
Contact: Linda Nolan (x6071)
RFA Link: PA-15-083 Ι K99-R00 Information-NCI
Supplement NIH

February 13 See Below Federal Metabolomics

Collaborative Activities to Promote Metabolomics Research

Supplemental funding for new interactive collaborations between basic or clinical researchers and metabolomics experts to add a metabolomics approach to existing Research Strategy   In addition to enhancing parent grant by adding metabolomics analyses, collaborative projects must include activities to increase expertise of biomedical research group in key aspects of metabolomics study design, analysis, and data interpretation.
Due Dates: February 11 (OSR) Ι February 13 (Sponsor)
Amount & Project Period: $100,000 direct costs - 1 year (must be within currently approved project period for existing parent award)
Eligibility: Principal Investigators holding P01, U19, R01, U01 (& other) award types
Contact: Linda Nolan (x6071)
FOA Link: PA-15-030

NEW

February 15 (LOI) All Ranks Non-federal Blood Cancers

Leukemia & Lymphoma Society
Translational Research Program

LLS encourages submission of proposals designed to accomplish one of the following:
1.  Define genetic/molecular predispositions to long-term and late-term effects associated 
w/standard therapies
2.  Development of novel therapies and/or novel therapeutic strategies for patients with non-
cutaneous T-cell lymphoproliferative disorders
3.  Development of novel therapies and/or novel therapeutic strategies for CLL patients, w/real     curative potential
4.  Development of novel therapies and/or novel therapeutic strategies for MDS & AML patients
5.  Development of novel therapies and/or novel therapeutic strategies for patients
w/high-risk myeloma
6.  Development of novel therapies and/or novel therapeutic strategies for indolent lymphoma patients

Due Dates: February 15 (Letter of Intent)
Application:  February 27 (OSR) Ι March 1 (Sponsor)
Amount & Project Period: $180,018/year (Direct Costs) - 3 years
Eligibility: All Ranks; need not be U.S. citizens
Contact: Linda Nolan (x6071)
Links: Translational Research Program
FY15RFP Announcement
Guidelines and Instructions
Submissions via FLUXX


and


February 16 All Faculty Non-federal microRNA Technology

Moffitt Pilot Studies Funding Opportunity with Rosetta Genomics, Inc.

Moffitt Cancer Center invites Moffitt investigators to apply for funds for a grant that focuses on using microRNA technology to diagnostically impact unmet medical needs.
Due Dates:  February 16 (4:00pm) to Brittany Palermo
Amount & Project Period: $70,000 - 12 months
Eligibility: All Faculty Ranks
Contact: Brittany Palermo (x1536)
R21/R03 NIH

NEW
February 16 All Ranks Federal Dissemination & Implementation Research

Dissemination and Implementation Research in Health

Identify, develop, evaluate and refine effective & efficient methods, systems, infrastructures, and strategies to disseminate & implement research-tested health behavior change interventions, evidence-based prevention, early detection, diagnostic, treatment & management, quality of life improvement services, and data monitoring & surveillance reporting tools into public health and clinical practice settings focusing on patient outcomes.
Due Dates: Standard Dates w/Letter of Intent due 30 days in advance
Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: R21:  $275,000 (Direct Costs) - 2 years
R03:  $100,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Links: R21:  PAR-13-054  Ι R03:  PAR-13-056
R21 NIH

February 16 All Ranks Federal Cancer Issues

Systems Science and Health in the Behavioral and Social Sciences

NCI is interested in research projects addressing cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and continuing care of cancer patients and families of cancer patients  Projects utilizing systems science methodologies to increase breadth, depth, and quality of behavioral research in cancer prevention and control would be of interest to NCI
Due Dates: Standard dates Final proposals due at OSR 48 hours prior to published sponsor deadline
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-047 
R25 NIH

February 17 (LOI) All Faculty Federal BDK2 Resource

NIH Big Data to Knowledge (BD2K) Initiative Research Education: Massive Open Online Course (MOOC) on Data Management for Biomedical Big Data

Over-arching goal is to complement and/or enhance training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.
This FOA focuses on Curriculum or Methods Development, seeking applications for development of an open, online educational resource.
Due Dates: February 17 (Letter of Intent)
March 13 (OSR) Ι March 17 (Sponsor)
Amount & Project Period: $50,000/year (Direct Costs) - 2 years
Eligibility: PD/PI should be an established investigator in the scientific area in which the application is targeted
PD/PI should have appropriate expertise or experience to oversee the design, testing and assessment of online learning resource
Contact: Linda Nolan (x6071)
RFA Link: RFA-LM-15-001
R25 NIH

February 17 (LOI) All faculty Federal BD2k Resource

NIH Big Data to Knowledge (BD2K) Initiative Research Education: Open Educational Resources for Sharing, Annotating and Curating Biomedical Big Data

Over-arching goal is to complement and/or enhance training of a workforce to meet the nation's biomedical, behavioral and clinical research needs  FOA focuses on Curriculum or Methods Development, seeking applications for development of open educational resources
Due Dates: February 17 (Letter of Intent)
March 13 (OSR) Ι March 17 (Sponsor)
Amount & Project Period: $50,000/year (Direct Costs) - 2 years
Eligibility: PD/PI should be an established investigator in the scientific area in which the application is targeted
PD/PI should have appropriate expertise or experience to oversee the design, testing and assessment of online learning resource
Contact: Linda Nolan (x6071)
RFA Link: RFA-LM-15-002
R01 NIH

February 19 All Ranks Federal IRB Issues

Empirical Research on Ethical Issues Related to Central IRBs and Consent for Research Using Clinical Records and Data

To explore two timely issues of significance for policy development relevant to:
     1) The principles and characteristics for central Institutional Review Boards (IRBs); and
     2) Consent and participant preferences for research using clinical records and data
Due Dates: February 17 (OSR) Ι February 19 (Sponsor)
Amount & Project Period: Budgets are not limited - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-OD-15-002

NEW

 Limited Submission
February 20 All Ranks Federal HIV-LMICs

National Comprehensive Cancer Network (NCCN)
***LIMTED SUBMISSION OPPORTUNITY***

Administrative Supplements to P30 Cancer Centers Support Grants (CCSG) to Stimulate Collaborative HIV Malignancy Research in Low and Middle Income Countries (LMIC)

Supplements are intended to:
     1) Strengthen collaborations between CC and LMIC investigators in cancer and other 
          disciplines;
     2) Lay groundwork for larger-scale studies supported by other mechanisms;
     3) Promote development of LMIC investigators and systematic tools/approaches for future
          inter-CC/LMIC research collaborations on HIV-associated cancers; and
     4) Encourage projects addressing health disparities, including women, minorities, and other
         vulnerable groups affected by HIV.
Due Dates: February 20 (4:00pm) - submitted electronically in PDF format to: Maureen.Ahearn@moffitt.org
Final proposal will be due March 11 (OSR) Ι March 13 (Sponsor)
Amount & Project Period: $200,000/year (TOTAL) 1 to 2 years
Eligibility: All Ranks
Contact: Maureen Ahearn (x8824)
U01 NIH

NEW
February 26 All Ranks Federal Physical Sciences & Oncology

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP)

To foster convergence of physical sciences approaches & perspectives w/cancer research to advance understanding of cancer biology and oncology by forming small trans-disciplinary teams of physical scientists and cancer biologists/physician scientists. Examples of physical scientists include engineers, physicists, mathematicians, chemists, and computer scientists
Due Dates: February 24 (OSR) Ι February 26 (Sponsor)
Amount & Project Period: Max. $500,000/year (Direct Costs) - 5 years
Eligibility: All Ranks -  Multi-PD/PI option is encouraged
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-021
UH2/UH3 NIH
Phase Innovation Awards Cooperative Agreement
NEW
February 26 (LOI) All Ranks Federal Molecular Analysis Technology

Assay Validation for High Quality Markers For NCI-Supported Clinical Trials

To improve development & validation of molecular diagnostics for treatment, control or prevention of cancer  UH2 phase supports analytical validation of assays that must be achieved w/in two years before an assay may undergo clinical validation   UH3 phase  supports  retrospective or prospective studies from NCI-supported or other clinical trials 
Due Dates: February 26 (Letter of Intent)
March 24 (OSR) Ι March 26 (Sponsor)
(Also July 8th and October 7th)
Amount & Project Period: UH2 Phase:  $275,000 (Total Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-095
UH3 NIH

Exploratory/Developmental Cooperative Agreement Phase II
NEW
February 26 (LOI) All Ranks federal Molecular Analysis Technology

Assay Validation for High Quality Markers For NCI-Supported Clinical Trials

Applications must propose to develop an existing assay using human specimens in a clinical laboratory into a molecular diagnostic assay that can be used in a clinical trial for the treatment, prevention or control of cancer.  UH3 phase will complete the clinical validation of the assay and prepare it and its marker for use in a clinical trial. 
Due Dates: February 26 (Letter of Intent)
March 24 (OSR) Ι March 26 (Sponsor)
(Also July 8th and October 7th)
Amount & Project Period: $250,000/year (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-096

NEW
February 27 All Ranks Non-federal Blood/Marrow

Aplastic Anemia & MDS International Foundation (AA&MDSIF)
2015 Research Grants

Topic areas include: (1) Promoting understanding of the etiology and pathogenesis of aplastic anemia, MDS, or PNH; (2) Improving symptom management and quality of life for aplastic  anemia, MDS, or PNH patients; and (3) Discovering new treatments for aplastic anemia, MDS, or PNH; Understanding/preventing complications of bone marrow failure conditions (e.g., blood clotting/thrombosis in PNH, iron overload in MDS, etc)
Due Dates: February 25 (OSR) Ι February 27 (Sponsor)
Amount & Project Period: $30,000/year - 2 years
Eligibility: Grants can be awarded to New Investigators and Established Investigators.  New Investigators are post-docs, instructors, and those who have been assistant professors <5 years. Established Investigators have been assistant professors >5 years or are associate or full professors
Contact: Linda Nolan (x6071)
Link: Guidelines


March 01 Graduate Students Non-federal Bone  Marrow Failure

Aplastic Anemia & MDS International Foundation (AA&MDSIF)

Summer Fellowship Grant Program

Will offer students an opportunity to engage in research under the supervision of an established institution  Students will learn valuable skills, gain experience and develop an interest in the science of bone marrow failure disease
Due Dates: February 26 (OSR) Ι March 1 (Sponsor)
Amount & Project Period: $5,000 - 10 week fellowship for the summer of 2015
Eligibility: Medical students and graduate students, in the biological sciences currently enrolled in a U.S. graduate program in the biomedical sciences, medical school or in an MD/PhD program
Contact: Linda Nolan (x6071)
RFA Link: Summer Fellowship Program Application


March 01 See Below Non-federal Melanoma

Melanoma Research Foundation - 2015 Research Awards

Due Dates: February 26 (OSR) Ι March 01 (Sponsor)
Contact: Linda Nolan (x6071)
Links: Request for Proposals 2015 Ι Application and Review Process

Career Development Awards

Researchers who are beginning a research career focused on melanoma and have not yet established strong federal funding for their research are eligible.   Use of relevant genetic models and human derived tumor samples is highly encouraged
Amount & Project Period: $50,000/yr. - 2 years
Eligibility: Postdocs & Jr. Faculty

Established Investigator Awards (EIA)

To established melanoma researchers, or senior researchers working in closely related fields wishing to move into melanoma research.  Use of relevant genetic models and human derived tumor samples is highly encouraged.
Amount & Project Period: $100,000/year - 2 years
Eligibility: Associate Professor or higher

2015 Team Awards

Teams of basic scientists and clinicians to address an unmet clinical need   Use of relevant genetic models and human derived tumor samples is required. Must address 1 of the Specific Topic Proposals (STPs) identified below:
1.  Prevention: Development of models and biomarkers.
2.  Identifying mechanisms and respective therapeutic strategies in less common molecular subsets of melanoma.
3.  Metastases: Dormancy and metastatic progression.
4.  CNS Metastases: Development of markers of risk and rational therapeutic approaches.
5.  Response to treatment: Mechanisms and respective biomarkers for predicting response and for monitoring therapeutic response.
6.  Resistance: Intrinsic/Innate/Primary resistance to immunotherapies in melanoma.
Amount & Project Period: $250,000/year - 2 years
Eligibility: Associate Professor or higher
U01 NIDDK

National Institute of Diabetes and Digestive and Kidney Diseases
March 02 (LOI) All Faculty Federal Pancreatic

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Clinical Centers (CSCPDPC -CCs)

For establishment of up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes.
Due Dates: March 02 (Letter of Intent) Ι March 31 (OSR) Ι April 02 (Sponsor)
Amount & Project Period: $270,000/year (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: RFA-DK-14-027
U01 NIDDK
National Institute of Diabetes and Digestive and Kidney Diseases
March 02 (LOI) All Clinical  Faculty Federal Pancreatic

Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer: Coordination and Data Management Center (CSCPDPC- CDMC)

For establishment of Coordination and Data Management Center (CDMC) for up to 9 Clinical Centers (CC), to conduct studies on chronic pancreatitis (CP) and factors that increase risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes.
Due Dates: March 02 (LOI) Ι March 31 (OSR) Ι April 02 (Sponsor)
Amount & Project Period: $1M (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
RFA Link: RFA-DK-14-028


NEW
March 03 (LOI) All Ranks Non-federal HIV

amfAR, The Foundation for AIDS Research
Impact Grants Exploring HIV Persistence and Eradication

Availability of funding to support research relevant to exploring HIV persistence and the potential for HIV eradication  Priority will be given to projects with a clear pathway to development of an implementable intervention in humans Impact Grants support in-depth development of concepts where preliminary data have indicated genuine promise in curing HIV and should include basic, animal and clinical (in vivo or ex vivo) research, and collaborations with other institutions.
     Must request log-in credentials no later than 3:00 PM ET on Friday, February 27, 2015.  
Due Dates: March 03 (Letter of Intent)
Hardcopy of Signed Face Page By Mail: Tuesday, March 24, 2015 Invited Applications:  March 26 (OSR) Ι March 30 (Sponsor)
Amount & Project Period: $2,000,000 (TOTAL) - 4 years
Eligibility: Must hold a doctoral-level degree
Must hold a faculty-level position
Must be affiliated with the applicant institution
Contact: Linda Nolan (x6071)
RFA Link: RFP
R01 NCI

March 06 All Ranks Federal Translation of Technologies

Academic-Industrial Partnerships for Translation of Technologies for Cancer Diagnosis and Treatment

Encourages applications from research partnerships formed by academic and industrial investigators, to accelerate translation of technologies, methods, assays or devices, and/or systems for preclinical or clinical molecular diagnosis or in vitro imaging designed to solve a targeted cancer problem  Will support clinical trials that test functionality, optimize, and validate the performance of the proposed translational work.
Due Dates: March 04 (OSR) Ι March 06 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-075


Spring 2015 Cycle - New
March 06 (LOI) All Ranks Non-federal PCOR

Patient-Centered Outcomes Research
Institute Spring Cycle 2015

Due Dates: March 06 (Letter of Intent)
Applications: May 01 (OSR) Ι May 05 (Sponsor)
Eligibility: All Ranks
Contact: Scott Mears - 1397

Improving Methods for Conducting Patient-Centered Outcomes Research

To address gaps in methodological research relevant to conducting patient-centered outcomes research (PCOR) 
Amount & Project Period: $750,000 (Direct Costs) - 3 years
Link: Improving Methods

Addressing Disparities

To fund comparative effectiveness research (CER) studies evaluating or comparing new and/or enhanced interventions to reduce or eliminate disparities in health and healthcare. Studies should focus on overcoming barriers that may disproportionately affect outcomes of specific groups of patients, or identify best practices for sharing results and information about patient-centered research across patient groups. 
Amount & Project Period: $1.5M (Direct Costs) - 3 years
Link: Addressing Disparities

Communication and Dissemination Research

For projects addressing critical knowledge gaps in communication and dissemination - of research results to patients, caregivers, and clinicians, as well between patients, caregivers, and clinicians
Amount & Project Period: $1.5M (Direct Costs) - 3 years
Link: Communication and Dissemination

 Assessment of Prevention, Diagnosis, and Treatment Options

To provide information that would inform critical decisions that face patients and caregivers, clinicians, policy makers, and healthcare system leaders. These decisions must be consequential and be occurring now in the absence of sound evidence about the comparative effectiveness of alternative approaches 
Amount & Project Period: $2.0M (Direct Costs) - 3 years
Link: Assessment of Prevention

Improving Healthcare Systems

To study comparative effectiveness of alternate features of healthcare systems (e.g., innovative technologies, incentive structures, service designs) intended to optimize quality, outcomes, and/or efficiency of care for patients served, and have most potential for sustained impact and replication within and across healthcare systems
Amount & Project Period: $5.0M (large studies) - 5 years Ι  $1.5M (small studies) - 3 years
Link: Improving Healthcare Systems

Large Pragmatic Studies to Evaluate Patient-Centered Outcomes 

Due Dates: May 01 (Letter of Intent)
Applications:  July 29 (OSR) Ι July 31 (Sponsor)
Amount & Project Period: TBD - 5 years
Link: Large Pragmatic Studies to Evaluate


&

NEW
March 09 Postdocs Non-federal Career Development

Society for Immunotherapy of Cancer - in partnership with Merck
2015 SITC-Merck Cancer Immunotherapy Clinical Fellowship Award

Funding support for a project in related to development and application of cancer immunotherapy in a unique clinical research area
Due Dates: March 5 (OSR) Ι March 09 (Sponsor)
Amount & Project Period: $100,000 - 1 year
Eligibility: MD or combined MD/PhD degree as a  postdoc, resident, research scientist or comparable position
SITC member in good standing at time of Submission
75% effort for this project
Contact: Linda Nolan (X6071)
Link: Fellowship Information
R01 Multiple Agencies

NEW
March 09 All Ranks Federal Multi-scale Models

Predictive Multiscale Models for Biomedical, Biological, Behavioral, Environmental and Clinical Research

NCI is interested in supporting development of predictive multi-scale models of cancer processes.  Models may be designed to elucidate basic mechanisms underlying cancer initiation and progression and/or address important translational, clinical or epidemiological questions related to cancer risk, prevention, diagnosis and treatment.
Due Dates: Letter of Intent due 30 days prior to due date
March 05 (OSR) Ι March 09 (Sponsor)
Amount & Project Period: <$500,000/year (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-085


March 17 Postdocs Non-federal Career Development

Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award

Supports all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention
Due Dates: March 12 (OSR) Ι March 16 by 4:00pm(Sponsor)
Amount & Project Period: Level I Funding: $50,000/year plus $2,000 for expenses
Level II Funding: $60,000/year plus $2,000 for expenses
Award duration:  3 years
Eligibility: Degree conferred April 15, 2014 - March 16, 2015 (MD, PhD, MD/PhD, DDS, DVM or equiv.)
Foreign candidates may apply to do their research only in the United States
Contact: Linda Nolan (X6071)
Link: Fellowship Award Application Guidelines

NEW
March 17 (Pre-app) Established Investigators Non-federal Myelodysplastic Syndromes

Taub Foundation  
Grants program for MDS Research

High-impact, innovative translational research on underlying causes of MDS and advancement of treatment & prevention.  Program specifically focuses on MDS research, exclusive of AML and MPN  Studies focusing on molecular genetics, epigenetics, splicing factors, stem cells, the microenvironment and novel therapeutic targets relevant to MDS are encouraged
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)
Full applications will be invited and due mid-August
Amount & Project Period: $200,000/year (Total) - 3 years
Eligibility: Independent investigators w/institutional support & laboratory space
U.S. citizenship not required; visa documentation not required
Contact: Linda Nolan (x6071)
Link: Taub Foundation Grants Program for MDS Research


NEW
March 17 Established Investigators Non-federal Multiple Myeloma

Multiple Myeloma Research Foundation (MMRF)
Senior Research Awards

To accelerate development of therapeutic approaches for myeloma; may include proposals in basic science, validation, or clinical research
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)
Amount & Project Period: $100,000/year (TOTAL) - 2 years
Eligibility: Established Investigators w/documented experience in blood cancer research or in research areas that are pertinent to multiple myeloma
Contact: Linda Nolan (x6071)
Links: MMRF Research Grants Ι 2015 Program Guidelines
R21 NIH

NEW
March 17 All Ranks Federal Molecular Analysis Technology

Innovative Molecular Analysis Technologies for Cancer Research

Emphasis of this FOA is on supporting development of novel molecular and cellular analysis capabilities with a high degree of technical innovation with potential to significantly affect and transform investigations exploring  molecular and cellular basis of cancer
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-002
R33 NIH

NEW
March 17 All Ranks Federal Molecular Analysis Technology

Advanced Development and Validation of Emerging Molecular Analysis Technologies for Cancer Research

Projects on advanced development of emerging molecular and cellular analysis technologies and validation in an appropriate cancer-relevant biological system Proof-of-principle of proposed technology or methodology has been established and supportive preliminary data are available   Proposal should reflect potential to produce a molecular analysis technology with a major impact in cancer-relevant research
Due Dates: March 13 (OSR) Ι March 17 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $300,000/year (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-003
R21 NIH

NEW
March 17 All Ranks Federal Biospecimen Science

Innovative Technologies for Cancer-Relevant Biospecimen Science

Projects on the inception and early-stage development of technologies addressing issues related to pre-analytical degradation of targeted analytes during collection, processing, handling, and storage of cancer-relevant biospecimens
Due Dates: March 13 (OSR) Ι March 17 (Sponsor) Letter of Intent due 30 days prior to due date
Amount & Project Period: $400,000 (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-004
R33 NIH

NEW
March 17 All Ranks Federal Biospecimen Science

Advanced Development and Validation of Emerging Technologies for Cancer-Relevant Biospecimen Science

Projects on advanced development and validation of technologies addressing issues related to pre-analytical degradation of targeted analytes during collection, processing, handling, and storage of cancer-relevant biospecimens
Due Dates: March 13 (OSR) Ι March 17 (Sponsor) Letter of Intent due 30 days prior to due date
Amount & Project Period: $300,000/year (Direct Costs) - 3 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
RFA Link: RFA-CA-15-005


NEW
March 19 Jr Faculty Non-federal Brain Cancer

The Sontag Foundation
2015 Distinguished Scientist Awards

For early career scientists with the potential to create new waves across the brain cancer field   Research focus on increased survival rates and improved recovery for patients and a cure or at the very least, treatments to make brain cancer a manageable chronic disease
Due Dates: March 17 (OSR) Ι March 19 (12:00pm - Sponsor)
Amount & Project Period: $150,000/yr - 4 years
Eligibility: Junior faculty in their first independent, full-time faculty appointment (appointed no earlier than March 1, 2012)
Contact: Linda Nolan (X6071)
Link: Applying for the Distinguished Scientist Award
R21 NCI

March 20 All Faculty Federal Clinical Collaborations

Opportunities for Collaborative Research at the NIH Clinical Center

NCI encourages bench-to-bedside research to:  increase understanding of molecular and physiological basis of health and disease; stimulate clinical discoveries about mechanisms underlying disease to develop improved prevention, diagnosis, and treatment; enable translation of basic discoveries into clinical practice to benefit personal and public health; foster training and mentoring of emerging scientists and physicians; and communicate research advances to the public.
Due Dates: March 18 (OSR) Ι March 20 (Sponsor)
Amount & Project Period: $500,000/year (Direct Costs) - 3 years (includes Clinical Center costs and intramural investigator's costs attributed to proposed research*)
*NIH Clinical Center costs and intramural investigator's costs will not be included in the award paid to the grantee
Eligibility: All Faculty - application must include at least one intramural scientist as Program Director/Principal Investigator or collaborator, and some of the research must be conducted at the NIH Clinical Center
Contact: Linda Nolan (x6071)
FOA Link: PAR-13-358
UH2/UH3 NIH
Phase Innovation Awards Cooperative Agreement

NEW
March 26 All Ranks Federal Assay Validation

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials

UH2 Phase supports analytical validation of assays for markers that must be achieved in 2 years before an assay may undergo clinical evaluation
Due Dates: March 24 (OSR) Ι March 26 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $275,000 (Direct Costs) - UH2 phase (2 years)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-095
UH3 NIH

Exploratory/Developmental Cooperative Agreement
Phase II
NEW
March 26 All Ranks Federal Assay Validation

Assay Validation For High Quality Markers For NCI-Supported Clinical Trials

The UH3 mechanism supports clinical validation of established assays for up to 3 years using specimens from retrospective or prospective studies w/purpose of developing assays to a point where their clinical utility could be assessed in other trials.
Due Dates: March 24 (OSR) Ι March 26 (Sponsor)  Letter of Intent due 30 days prior to due date
Amount & Project Period: $250,000/year (Direct Costs) - UH3 phase (3 years)
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-096


NEW
March 27 Jr Faculty Non-federal Radiation Oncology

American Society for Radiation Oncology

Due Dates: March 25 (OSR) Ι March 27 (Sponsor)
Contact: Linda Nolan (x6071)

Comparative Effectiveness Research Award

To stimulate research focused on evaluating the effectiveness, complication profile, cost and cost-effectiveness of various radiation therapy treatments, as well as the comparative effectiveness when compared to other therapies.
Amount & Project Period: $50,000/year - 2 years
Eligibility: Must be active members of ASTRO
Must be a board-certified or board-eligible physician or physicist in radiation oncology or a radiobiologist at time of award
At least 40% full-time professional effort must be devoted to goals of award
Links: Comparative Effectiveness Award
Award Requirements & Obligations

Junior Faculty Career Research Training Award

Specific areas of interest may include: (1) Basic and clinical research in radiation therapy sciences; (2) Projects developing innovative techniques, new methods or special equipment leading to better patient care; (3) Aspects of health care planning and delivery, including outcome evaluation; (4) Development of programs in health education relevant to radiation therapy sciences
Amount & Project Period: $100,000/year - 2 years
Eligibility: Must be w/in first 3 years of Jr Faculty appointment
Applicants & mentors must be active ASTRO members
At least 75% full-time professional effort must be devoted to goals of award
Links: Jr Faculty Award Ι Award Requirements and Obligations

 Seed Grant

Specific areas of interest may include: (1) Basic and clinical research in radiation therapy sciences; (2) Projects developing innovative techniques, new methods or special equipment leading to better patient care; (3) Aspects of health care planning and delivery, including outcome evaluation; (4) Development of programs in health education relevant to radiation therapy sciences
Amount & Project Period: $25,000 - 1 year
Eligibility: Must be in a U.S. residency or fellowship
Mentors must be active members of ASTRO.
Must not have previously served as PI or co-PI on grants totaling $50,000 or more in a single calendar year
At least 75% full-time professional effort must be devoted to goals of award
Links: Seed Grant Guidelines Ι Award Requirements & Obligations
April 01 All Faculty Federal PCOR-Conference Support

Patient-Centered Outcomes Research Institute    
Engagement Award (EAIN): Research Meeting and Conference Support

Available funding support for meetings and conferences that align with PCORI's Mission and Strategic Plan and facilitate expansion of patient-centered outcomes research/clinical comparative effectiveness research (PCOR/CER)
Applicant Town Hall Sessions: February 17th, 3:00 p.m. – 4:00 p.m. (ET) 
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: One-time award: $50,000 (Total Costs) -1 year
Multi-year award:  $250,000 (Total Costs) - 2 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
Link: Application Information


Annual Due Date
April 01 See Below Non-federal Career Development

American Cancer Society

Due Dates: Mar 30 (OSR) Ι Apr 01 (Sponsor-Electronic) Ι Apr 02 (Hardcopy)
Contact: Linda Nolan (x6071)

Mentored Research Scholar Grant in Applied and Clinical Research

For beginning investigators to become independent as either clinician scientists or cancer control and prevention researchers.
Amount & Project Period: $135,000/year (Direct Costs) - 5 years
Eligibility: Within initial 4 years of first independent appointment
Link: Mentored Research Scholar Grant in Applied and Clinical Research
 

Research Scholar Grants in Basic, Preclinical, Clinical and Epidemiology Research

Supports investigator-initiated research projects in basic, preclinical, clinical and epidemiologic research
Amount & Project Period: $200,000/year (Direct Costs)* - 4 years
Eligibility: Must be independent, self-directed and w/in 6 years of first academic appointment.*
Link: Research Scholar Grants
*Exception for research studies in psychosocial, behavioral, health policy or health services which address cancer health equity and disparities.  Investigators can be at any stage of their career and may request $400,000/year direct costs for up to 5 years.
 

Postdoctoral Fellowships

 Support the training of researchers who have received a doctoral degree to provide initial funding leading to an independent career in cancer research.
Amount & Project Period: 3-year award with progressive stipends of $48,000, $50,000, and $52,000/year, plus $4,000/year fellowship allowance
Eligibility: Must  be U.S. citizens
Link: Postdoctoral Fellowships

Pilot and Exploratory Studies Using Community-Based Participatory Research (CBPR) to Achieve Cancer Health Equity

To stimulate research on effective interventions to reduce cancer health disparities (at any stage of the cancer continuum) and achieve cancer health equity using community-based participatory research (CBPR).
Amount & Project Period: $100,000 (TOTAL) - 2 years
Eligibility: Independent investigators at all stages of career are eligible
RFP: CBPR Request for Proposals
 

Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

Pilot and exploratory research studies whose purpose is to test interventions, develop research methodologies, and explore novel areas of research in palliative care of cancer patients and their families 
Amount & Project Period: $60,000/year (Direct Costs) - 2 years
Eligibility: Independent investigators at all stages of their career are eligible to apply
RFA Link: Palliative Care Request for Proposals


The Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services

A call for research that evaluates the impact of the many changes now occurring in the healthcare system with a particular focus on cancer prevention, control, and treatment Efforts focusing on improving access to care may also impact inequities that contribute to health disparities.
Amount & Project Period: $165,000/year (Direct Costs) - 4 years
$200,000/year (Direct Costs) - 5 years (Health Equity focus only)
Eligibility: Independent investigators at all stages of their career are eligible to apply
Contact: Linda Nolan (x6071)
RFA Link: RFA


April 01 Postdocs Non-federal Career Development

Cancer Research Institute
Irvington Post Doctoral Fellowships

Seeks hypothesis driven, mechanistic studies in both immunology and tumor immunology
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: Stipend of:
      $50,000 Year 01
      $53,000 Year 02
      $57,000 Year 03 and
      $1,500/year for research support
Eligibility: Must have doctoral degree by date of award activation Applicants >5 or more years of relevant postdoctoral experience are not eligible; except M.D. applicants, who should not include years of residency in calculation
No citizenship restrictions
Contact: Linda Nolan, x6071
Links: CRI Grants and Programs Postdoctoral Fellowship Application Guidelines

NEW
April 01 All faculty Non-federal Leukemia

When Everyone Survives (WES) Leukemia Research Foundation
2015 request for Proposals in Leukemia Research

 Laboratory, translational, or clinical research related to acute leukemia
Due Dates: March 30 (OSR) Ι April 01 (Sponsor)
Amount & Project Period: $50,000 (Total) - 1 year
Eligibility: All Faculty
Contact: Linda Nolan, x6071
RFP Link: 2015 RFP


NEW
April 21 Postdocs/Fellows Non-federal Career Development

Multiple Myeloma Research Foundation (MMRF)
Research Fellow Awards

To accelerate development of therapeutic approaches for myeloma; may include proposals in basic science, validation, or clinical research
Due Dates: April 17 (OSR) Ι April 21 (Sponsor)
Amount & Project Period: $75,000 - 1 year
Eligibility: Ph.D., M.D. or equivalent degree at post-doctorate, clinical fellow or assistant professor levels and beginning studies in multiple myeloma field under supervision of a research mentor
Contact: Linda Nolan (x6071)
Links: MMRF Research Grants Ι 2015 Program Guidelines
R01 NIH

NEW
May 12 All Ranks Federal Prevention-Native Americans

Interventions for Health Promotion and Disease prevention in Native American Populations  

Develop, adapt, and test the effectiveness of health promotion and disease prevention interventions in Native American (NA) populations
Due Dates: May 10 (OSR) Ι May 12 (Sponsor)
Amount & Project Period: Budgets are not limited - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-14-260
U01 NIH

May 17 (LOI) All Faculty Federal Population Science & Cancer

Bridging the Gap Between Cancer Mechanism and Population Science

Any project that poses and addresses a challenging cancer question that can only be addressed by linking these two ends of the cancer spectrum -- biological mechanism and population
Due Dates: May 17 (Letter of Intent) (also Oct. 4th)
June 15 (OSR) Ι June 17 (Sponsor) (also Nov. 4th)
Amount & Project Period: $750,000/yr. (Direct Costs) - 5 years
Eligibility: All Faculty
Contact: Linda Nolan (x6071)
FOA Link: PAR-13-081


and
Exp. May 28
Int. June 03		 All Ranks Federal Healthcare Research

National Science Foundation & National Institutes of Health
Smart and Connected Health (SCH)

The goal of this interagency program is development of next generation health and healthcare research through high-risk, high-reward advances in understanding of and applications in information science, technology, behavior, cognition, sensors, robotics, bio-imaging, and engineering.  Collaboration between academic, industry, non-profit and other organizations is strongly encouraged to establish better linkages between fundamental science, clinical practice and technology development, deployment and use.
Due Dates: Exploratory:  May 26 (OSR) Ι May 28 (Sponsor)                             
Integrative Props:  June 1 (OSR) Ι June 03 (Sponsor)
Amount & Project Period: Exploratory: $170,000/year (Direct Costs) - 3 years
Integrative:  $370,000/year (Direct Costs) - 4 years
Eligibility: All Ranks - An investigator may participate as PI, co-PI, Project Director, Senior Personnel or Consultant in no more than two proposals submitted in response to this solicitation.
Contact: Linda Nolan (x6071)
FOA Link: NSF-13-543




NEW
May 29 All Ranks Non-federal Drug Discovery

Sanford Ι Burnham Medical Research Institute
Florida Translational Research Program
2015 Spring Call for Submissions

Concept or assay development projects for use in pre-therapeutic discovery via high-throughput screening - development of innovative biochemical and cell-based assays for biological targets, pathways, or processes for which there are limited selective and potent small molecule modulators available
High-throughput screening (HTS)-ready assays - well-developed, HTS-ready assays suitable for high-throughput screening of the Sanford-Burnham library of compounds for the purpose of identifying small-molecule modulators of the target, pathways, or processes of interest Validated hits for the discovery of pre-therapeutic lead compounds - proposals that aim to further research and development of existing small-molecule chemical scaffolds for use in vivo
Due Dates: May 27 (OSR) Ι May 29 (Sponsor)
Amount & Project Period: No funding - 1 year     Provides access to technological resources for drug development facilitating an interdisciplinary, collaborative approach to the establishment of a pipeline of potential new treatments for today's most challenging and unmet medical needs
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
Link: Florida Translational Research Program at Sanford-Burnham
S10 NIH

NEW
May 29 All Ranks Federal Equipment

Shared Instrumentation Grant (SIG) Program

Encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems  Types of instruments supported include: X-ray diffraction systems, nuclear magnetic resonance (NMR) and mass spectrometers, DNA and protein sequencers, biosensors, electron and confocal microscopes, cell-sorters, and biomedical imagers
Due Dates: May 27 (OSR) Ι May 29 (Sponsor)
Amount & Project Period: Maximum: $600,000 - 1 year
Eligibility: PD/PI should have documented technical expertise directly related to chosen instrument.
Major User group of 3 or more individuals must be identified. Each must be a PD/PI on a distinct NIH award with one of the following activity codes: R01, DP1, DP2, P01, P50, R37, and U01. Major Users must have substantial interests in and needs for the instrument.
Major Users can be researchers from the same department or from several departments, divisions or schools at applicant institution, or from nearby or regional institutions.
Contact: Christi Craig (x1458)
FOA Link: PAR-15-088


June 01 All Ranks Non-federal Pediatric Brain Cancer

The Cure Starts Now Foundation
Research Grants

Funds search for a cure for brainstem glioma and other forms of pediatric brain cancer in the hopes of curing all cancers Focus is on Diffuse Intrinsic Brainstem Glioma (DIPG), and to support translational and clinical research projects in those areas.
Due Dates: May 28 (OSR) Ι June 01 (Sponsor) (Hardcopy by June 5th)
Amount & Project Period: $100,000 - 1 year
Eligibility: All Ranks
Contact: Shaina Sine (x3658)
Link: Research & Grants
R21 NIH

NEW FOA #
June 17 All Ranks federal Health Disparities

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities

Basic research studies into the biological/genetic causes and mechanisms of cancer health disparities
Due Dates: June 15 (OSR) Ι June 17 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-092
R01 NIH

NEW FOA #
June 17 All Ranks federal Health Disparities

Basic Cancer Research in Cancer Health Disparities

To investigate biological/genetic bases of cancer disparities, such as (1) mechanistic studies of biological factors associated with cancer disparities, including those related to basic research in cancer biology or cancer prevention intervention strategies, (2) development & testing of new methodologies & models, and (3) secondary data analyses
Due Dates: June 15 (OSR) Ι June 17 (Sponsor)
Amount & Project Period: $250,000 (Direct Costs) - 5 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
PAR Link: PAR-15-093
R21 NIH


NEW FOA #
June 22 All Ranks Federal Career Development

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research

Supports eligible investigators from groups that have been shown to be underrepresented in the biomedical, clinical, behavioral, and social sciences workforce. Provides a bridge to investigators that have completed their research training and may need extra time to develop a larger research project grant application.
Due Dates: June 18 (OSR) Ι June 22 (Sponsor)
Amount & Project Period: $275,000 (Direct Costs) - 2 years
Eligibility: All Ranks
Contact: Linda Nolan (x6071)
FOA Link: PAR-15-053


NEW
June 30 All Ranks Non-federal Leukemia

Children's Leukemia Research Association, Inc.
Research Grants

Funds the most promising studies to isolate the causes of leukemia 
Due Dates: June 26 (OSR) Ι June 30 (Sponsor)
Amount & Project Period: $30,000 - 1 year
Eligibility: All Ranks
Contact: Linda Nolan  (x6071)
Link: Research Grants
Toolbox
Funding Opportunities

Funding Opportunity Calendar
OSR's Grant News
grants.gov
NCI Funding Opportunities
NIH Guide to Grants & Contracts

RaceTracks

 Federal Opportunities
Moffitt-Sponsored (Intramural) Opportunities
Opportunities Focused on Thoracic Oncology		 Grant Preparation

Proposal Submission Form
Grants.gov Instructions
PHS398 Instructions
NIH 2590 Instructions

News

 NIH Research Matters
The Cancer Letter
NIH News & Events
Federal Register
Science 360 News
 Other

PubMed
National Cancer Institute

Clinical Research

Who To Call in Clinical Research
Clinical Research FAQs
Data Safety Monitoring Plan
Liberty IRB
USF IRB
Questions?
MRISignals@moffitt.org